Artal Group takes stake in Crispr Therapeutics By: MarketMinute.com Stock News February 26, 2018 at 16:21 PM EST Artal Group acquired 50,000 shares of Crispr Therapeutics (Nasdaq: CRSP). Shares of the gene editing company leaped $5.30 to close at $48.34. Related Stocks: Crispr Therapeutics Ag